China has over 500 million smart phone users which is over 1/3 of global users and close to 400 million 4G users. We also have over 2,000 healthcare apps already. However, the failure rate of apps is running at over 40%. Value is the key to not only the traditional major stakeholder groups, such as patient, practitioner, provider, payer, distributor and pharmaceutical companies, but also the new disruptors, including new players bringing new value and capital to the sector.
Patients and practitioners in China will have access to a growing number of apps with new ways of engaging and interacting across platforms, expect a lot more innovation, investment and cooperative models.
Care in the palm of your hand